


Walter Reed Secures $4.9 Million Grant to Study MDMA for PTSD Treatment
Walter Reed National Military Medical Center has initiated an MDMA study for PTSD in soldiers, receiving a $4.9 million DoD grant.
Overview
Walter Reed National Military Medical Center has received a $4.9 million grant from the Department of Defense to study MDMA’s effects on PTSD among active-duty soldiers. Involving 91 participants, the research will focus on psychological flexibility and the unique therapeutic benefits of MDMA. This project builds on a systemic review showcasing MDMA's potential therapeutic advantages, marking a significant step in military mental health treatment, with the possibility of broadening the use of psychedelics in military therapy. This study represents an evolving paradigm in addressing mental health challenges within the armed forces.
Content generated by AI—learn more or report issue.

Get both sides in 5 minutes with our daily newsletter.
Analysis
- Walter Reed National Military Medical Center will conduct a groundbreaking study of MDMA for treating PTSD in active-duty soldiers, funded by a $4.9 million government grant.
- This study aims to explore the therapeutic effects of MDMA, which proponents believe can significantly aid those suffering from PTSD, especially veterans.
- The research reflects a shift in perception about psychedelics as potential treatment options for mental health issues within the military.
Articles (15)















FAQ
No FAQs available for this story.
History
- 3M6 articles